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ABSTRACT 
Apocrine carcinoma of breast is a very rare form of breast malignancy represent about 0.4% of all invasive ductal carcinoma (IDC). 
Though clinical presentation and gross appearance are indistinguishable from classic IDC, they have distinct cytological, 
histopathlogical and immunohistochemical features. Tumor cells are characterized by typical apocrine features large cells with 
abundant eosinophilic granular cytoplasm and large pleomorphic vesicular nuclei and prominent nucleoli. It tends to show estrogen, 
progesterone receptors and her2/neu negativity and show positivity for Gross Cystic Disease Protein Fluid -15 (GCDPF-15). We 
report a case of 65 year old female presenting clinically as lump in right breast in upper inner quadrant since four months and having 
similar cytological, histopathological and immunohistochemical features. 
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INTRODUCTION 
Apocrine carcinoma of breast is a very rare form of breast 
malignancy represent about 0.4% of all invasive ductal 
carcinoma (IDC)[1]. Clinical presentation and gross appearance 
are indistinguishable from classic IDC differing only in their 
cytological appearance. Tumor cells are characterized by 
typical apocrine features large cells with abundant eosinophilic 
granular cytoplasm and large vesicular nuclei. [2] It tends to 
show estrogen, progesterone receptors and her2/neu negativity 
and expression of Gross Cystic Disease Protein Fluid -15 
(GCDPF-15).[3,4,5] We report a case of invasive apocrine 
carcinoma of breast as it is a very rare histological entity. 
CASE REPORT 
A 65 years old female presented with a right breast lump in 
upper inner quadrant since four months, gradually increased in 
size. On clinical examination of breasts, overlying skin showed 
puckering. There was no nipple retraction and any discharge. 
No axillary lymphadenopathy. Fine needle aspiration was done 
which show marked cellular smear, having large pleomorphic 
nuclei with prominent nucleoli and eosinophilic granular 
cytoplasm with probable diagnosis of apocrine 
carcinoma.(Fig.1) In view of cytological report, modified 
radical mastectomy was done and specimen sent for 
histopathological examination. Cut section showed tumor of 
size 7×6×5 cm, fleshy along with axillary and apical lymph 
nodes. Haematoxylin and eosin stained sections examined 
under light microscopy showed large cells arranged in tubules, 
glandular pattern and sheets having abundant eosinophilic 
granular cytoplasm with distinct cell borders along with large 
round to oval nuclei with vesicular chromatin and prominent 
nucleoli. (Fig 2 & 3) The case was labelled as apocrine 
carcinoma of right breast. All axillary and apical lymph nodes, 
surgical margin, pectoral fascia, skin, nipple and areola were 
free from tumor infiltration.  
 
 
Fig1: Cytology (FNAC) shows hypercellular smear, cluster, 
sheets, and isolated cells having abundant granular 
cytoplasm (MGG,  40X) 
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Fig 2: Microphtograph shows tubules and glandular cells 
having abundant granular cytoplasm (H& E, 10X) 
 
 
Fig 3: Microphtograph  shows large cells having abundant 
granular cytoplasm with distinct cell borders & large 
vesicular nuclei (H& E, 40X) 
Immunohistochemistry was done which showed negativity for 
Estrogen Receptor (ER), Progesterone receptor (PR) and 
her2/neu. GCDFP-15 positivity reported on molecular analysis. 
(Fig 4) 
 
Fig 4: Immunohistochemistry microphotograph shows 




As apocrine carcinoma is a very rare category of breast 
carcinoma, very less frequently encountered and so less often 
studied.  
The definition and consequently the reported incidence of these 
tumors varies considerably included this entity under the group 
of “relatively rare carcinomas”. [6]  Frable and Kay (1968) in a 
survey which covered a 16 years period stated that apocrine 
carcinoma account for 1% of mammary carcinomas.7 Azopardi 
reported an incidence of apocrine carcinoma between 0.3 – 
0.4% of all breast carcinomas. [1] 
Japaze et al., 2005 proposed criteria are (1) Apocrine features 
should consist of 75% of cells (2) Large cells with eosinophilic, 
granular cytoplasm (3) Nucleus to cytoplasm ratio of 1:2 or 
more (4) Nucleus large round and vesicular, may be 
pleomorphic (5) Sharply defined cell borders. Minor criteria 
includes prominent nucleoli in >50% of fields and apical 
cytoplasmic snouts into luminal spaces. [3,8] In this case fulfill all 
the criteria by Japanze et al. [8] 
Apocrine carcinoma should be differentiated from other 
histological types of breast carcinoma that is oncocytic 
carcinoma, secretary type, lipid rich type, histiocytoid type and 
which we have done in our study. From our observation it can 
be said that Japaze criteria could be reasonably helpful in 
differential diagnosis. 
Apocrine carcinomas always show moderate nuclear 
pleomorphism and tubule formation is rarely greater than 75%. 
Mitotic count is variable. -Therefore most apocrine carcinomas 
are Scarff-Bloom-Richardson grade 2-3.[5] Our case belonged to 
grade 1 as moderate nuclear pleomorphism and low mitotic 
count seen. Ongoing studies about apocrine carcinoma revealed 
estrogen, progesterone receptors and her2/neu negativity and 
GCDFP-15 protein positivity. [3,5] 
Apocrine carcinoma has a prognosis similar to classic IDC as 
staging  and grading. [2]  However there seems to be a potential 
unique response to androgen administration as a part of 
treatment; that may justify identifying apocrine carcinoma as an 
entity different from usual ductal carcinoma which was 
emphasized by Tsutsumi. [4] 
CONCLUSION 
Apocrine carcinoma is a rare and distinct morphological type of 
invasive breast cancer & have  unique  respons  for androgen 
administration . 
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